TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	674.43	666.53	969.62	802.42	702.05	737.08
Revenue Growth (YoY)	-19.16%	-31.26%	20.84%	14.30%	-4.75%	29.62%
Cost of Revenue	352.87	339.22	489.45	353.93	343.33	368.15
Gross Profit	321.56	327.31	480.17	448.49	358.72	368.92
Selling, General & Admin	211.33	224.09	380.38	340.9	276.14	259.59
Research & Development	94.41	93.22	77.46	81.8	80.45	71.53
Operating Expenses	307	316.61	457.84	423.19	356.59	331.87
Operating Income	14.56	10.7	22.33	25.3	2.13	37.05
Interest Expense	-1.06	-1.61	-2.77	-2.39	-1.97	-1.95
Interest & Investment Income	5.39	4.69	1.55	0.14	0.04	0.07
Currency Exchange Gain (Loss)	-	-	-	0.01	0.44	-0.55
Other Non Operating Income (Expenses)	12.91	11.24	0.93	0.07	0.71	0.16
EBT Excluding Unusual Items	31.79	25.02	22.03	23.13	1.35	34.78
Gain (Loss) on Sale of Assets	-	-	-	-	0.91	1.35
Pretax Income	31.79	25.02	22.03	23.13	2.26	36.13
Income Tax Expense	4.78	4.01	3.46	4.86	0.38	10.59
Net Income	27.01	21.01	18.57	18.27	1.87	25.54
Net Income to Common	27.01	21.01	18.57	18.27	1.87	25.54
Net Income Growth	35.03%	13.11%	1.69%	875.17%	-92.67%	292.17%
Shares Outstanding (Basic)	59	59	53	49	49	48
Shares Outstanding (Diluted)	59	59	53	49	49	48
Shares Change (YoY)	1.80%	11.37%	8.03%	0.89%	0.42%	-0.03%
EPS (Basic)	0.46	0.36	0.35	0.37	0.04	0.53
EPS (Diluted)	0.46	0.36	0.35	0.37	0.04	0.52
EPS Growth	32.68%	1.66%	-5.41%	861.49%	-92.66%	289.82%
Free Cash Flow	79.35	159.42	-41.51	48.46	11.19	71.96
Free Cash Flow Per Share	1.34	2.70	-0.78	0.99	0.23	1.49
Dividend Per Share	0.350	0.350	0.285	0.033	-	0.349
Dividend Growth	22.81%	22.81%	763.64%	-	-	-10.00%
Gross Margin	47.68%	49.11%	49.52%	55.89%	51.10%	50.05%
Operating Margin	2.16%	1.60%	2.30%	3.15%	0.30%	5.03%
Profit Margin	4.00%	3.15%	1.92%	2.28%	0.27%	3.46%
Free Cash Flow Margin	11.77%	23.92%	-4.28%	6.04%	1.59%	9.76%
EBITDA	32.78	28.61	39.52	40.86	16.42	50.35
EBITDA Margin	4.86%	4.29%	4.08%	5.09%	2.34%	6.83%
D&A For EBITDA	18.22	17.92	17.19	15.56	14.29	13.3
EBIT	14.56	10.7	22.33	25.3	2.13	37.05
EBIT Margin	2.16%	1.60%	2.30%	3.15%	0.30%	5.03%
Effective Tax Rate	15.04%	16.02%	15.70%	21.02%	17.01%	29.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.